Enzo Biochem Inc is a bioscience company... Show more
The Moving Average Convergence Divergence (MACD) for ENZ turned positive on April 15, 2025. Looking at past instances where ENZ's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ENZ's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where ENZ advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where ENZ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on April 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ENZ as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
a developer of molecular technology products
Industry MedicalSpecialties